亚宝药业

600351 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

4.5B ($648.3M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

2.7B

Net Income

224.0M

Gross Margin

N/A

Op. Margin

11.2%

Net Margin

8.3%

ROE

7.7%

ROA

6.3%

D/E

0.22

Dividend Yield

N/A

EPS

N/A

Current Ratio

2.68

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 亚宝药业

Ticker	600351
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业